Radiation Proctitis Management

Introduction to Radiation Proctitis

Radiation proctitis is a complication of radiation therapy that can cause rectal bleeding, fecal incontinence, and other symptoms, requiring a comprehensive management approach 1, 2, 3

The European Society for Medical Oncology (ESMO) and the American College of Oncology recommend sucralfate enemas as the first-line treatment for managing chronic radiation-induced proctitis in patients with rectal bleeding, with a recommended dose of 2g sucralfate suspension in 30-50ml water, administered twice daily for at least 6 weeks 1, 2, 3
Basic bowel care, including maintaining adequate hydration, considering potential transient lactose intolerance, and optimizing stool consistency, should be implemented alongside sucralfate enema therapy, as recommended by ESMO and the American College of Oncology 1, 2, 3

Argon plasma coagulation (APC) is the most effective endoscopic treatment for persistent bleeding in patients with radiation-induced proctitis, resolving 80-90% of bleeding cases, but has a serious complication rate of 7-26%, and should be used with caution in chronically ischemic tissues 4, 5, 6
Alternative endoscopic options include heater probe, bipolar electrocoagulation, YAG laser, potassium titanyl phosphate laser, radiofrequency ablation, and cryoablation, as suggested by the European Society of Gastrointestinal Endoscopy and the American Society for Gastrointestinal Endoscopy 5, 6
Formalin application may be more effective for severe radiation proctitis when argon plasma coagulation fails, with options including 3.6-4% formalin solution for irrigation or direct application of gauze soaked in formalin (4% or 10%) 5

The American Society for Therapeutic Radiology and Oncology recommends modern radiotherapy techniques, such as IMRT, VMAT, and tomotherapy, to reduce the risk of radiation-induced proctitis, with a strength of evidence based on clinical trials 2
Amifostine (≥340 mg/m²) before radiation therapy is recommended to reduce the risk of radiation-induced proctitis, with a strength of evidence based on clinical trials 2
Sulfasalazine 500mg orally twice daily during pelvic radiation therapy is recommended to reduce the incidence and severity of radiation-induced enteropathy, with a strength of evidence based on clinical trials 2

Surgery should be considered only as a last resort for refractory cases of radiation-induced proctitis, with a strength of evidence based on clinical trials 2, 3
Hyperbaric oxygen therapy induces neo-vascularization, tissue re-oxygenation, and collagen deposition, and is effective for soft tissue necrosis or chronic proctitis, as recommended by the European Society of Hyperbaric Medicine and the Undersea and Hyperbaric Medical Society 6

Flexible endoscopy is essential to determine the cause of bleeding and rule out other pathologies in patients with radiation proctitis, with basic bowel care including maintenance of adequate hydration and consideration of potential transient lactose intolerance and presence of bacterial pathogens 4, 7, 3, 2
Sigmoidoscopy is recommended for investigating patient-reported bleeding and evidence of occult fecal blood, with regular follow-up with a multidisciplinary team, as recommended by the American Gastroenterological Association 6

Patients should eliminate dairy products, alcohol, and high-osmolarity supplements from their diet, as recommended by the American Dietetic Association 8
A diet consisting of small, frequent meals and clear liquids should be implemented to help manage fecal incontinence, according to the American College of Gastroenterology 8
A stepped approach to nutrition is recommended, starting with oral nutrition and supplements, progressing to enteral nutrition if necessary, and implementing home parenteral nutrition without delay when oral/enteral nutrition is inadequate, as recommended by the American Gastroenterological Association and the American Society for Parenteral and Enteral Nutrition 9
Loperamide is an effective medication for managing fecal incontinence, with a recommended initial dose of 4 mg followed by 2 mg every 4 hours or after each unformed stool (maximum 16 mg/day), as suggested by the American College of Gastroenterology 8

Patients with fecal incontinence secondary to radiation proctitis should start with a stepped approach that begins with dietary modifications, anti-diarrheal medications such as loperamide, and physical therapy of the pelvic floor, before considering more invasive interventions, as recommended by the American College of Gastroenterology 8